ARLINGTON, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ: KALA) (“Kala” or the “Company”) today announced the initial commercial deployment of the Bionic Intelligence Research Agent ...
Kala Pharmaceuticals stock soared as much as 81% premarket on Friday, continuing a supercharged rally earlier in the week sparked by the Food and Drug Administration approving a trial for a drug to ...
Next-Generation Agentic AI Platform Achieves Live Enterprise Deployment, Delivering Secure, Scalable, Autonomous Research Solutions to Global Biotechnology and Pharmaceutical Organizations ARLINGTON, ...
The launch follows the Company's March 11 announcement that its first AI agent would ship within 14 days, a commitment Kala has met on schedule, demonstrating the Company's ability to execute on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results